Michael Aragon, MD

DocwireNews

<p>As nephrology continues to advance, so must the methods for managing dialysis patients. One area ripe for innovation is the transition from peritoneal dialysis (PD) to home hemodialysis (HHD).</p>
<h2><strong>The Case for Home Hemodialysis</strong></h2>
<p>While peritoneal dialysis can serve patients well in the early stages, many patients require a transition to another form of therapy as their condition progresses. Home hemodialysis offers numerous benefits, including improved patient outcomes, greater flexibility, and better alignment with patient lifestyles.</p>
<p>Despite these advantages, the shift to HHD remains underutilized. Data from the <a href="https://usrds-adr.niddk.nih.gov/2023" target="_blank" rel="noopener">United States Renal Data System</a> indicates that nearly half of all PD patients transition off therapy within three years. This transition is not a failure, but an inherent part of PD and a patient’s evolving needs. Unfortunately, through late recognition and/or acknowledgment of the need to transition, the current system inadvertently funnels these patients into in-center hemodialysis, often without presenting HHD as an option.</p>
<h2><strong>Addressing Myths and Misconceptions</strong></h2>
<p>A significant barrier to the wider adoption of HHD after PD is the persistence of outdated myths. Misconceptions about the complexity of the therapy, the need for extensive caregiver support, and the suitability of patients can bias nephrologists, nurses, and clinical care teams from offering HHD to patients who need to transition off PD.</p>
<p>The belief that only certain types of patients—such as those with a high level of education, a dedicated support system, and a large home—can manage HHD are no longer validated by real-world data. Modern technology and improved training programs have addressed these issues, making HHD a viable option for a broader range of patients. Advances such as simplified dialysis machines and improved infection control techniques have reduced barriers to training and the burden of therapy, thereby broadening the population of patients who can successfully manage HHD.</p>
<h2><strong>Leveraging Technology for a Seamless Transition</strong></h2>
<p>The role of technology in simplifying the transition cannot be overstated. Options such as the Outset Medical Tablo® Hemodialysis System, designed for ease of use across the care continuum, exemplify how innovation is making HHD more accessible.</p>
<p>These technologies offer automation, electronic medical record connectivity, and enhanced safety features, reducing the burden and apprehension for patients and health care professionals. Innovative systems designed through extensive human factors testing focus on ease of use, making them less intimidating for patients and care partners alike.</p>
<h2><strong>Real-World Success </strong></h2>
<p>Success in transitioning to HHD is not just theoretical. Partnerships with hospitals and health care organizations demonstrate that, with the proper support and infrastructure, patients can successfully transition from PD to HHD without needing an in-center setting. For example, some health care systems have developed direct-to-home programs where patients are identified during hospital stays, educated about HHD, and trained directly at home.</p>
<h2><strong>Overcoming Logistical Challenges</strong></h2>
<p>Logistics often pose the most significant challenge in transitioning patients to HHD. Key areas for improvement include increasing access to home dialysis programs as well as overcoming health care and dialysis provider inertia that defaults patients to in-center care. It is crucial to address the limited availability of home hemodialysis programs. Currently, in the United States, only about 30% of dialysis facilities list HHD as an option, and many do not actively have a patient on the therapy.</p>
<p>Another challenge is the inadequate training of nephrologists in home therapies, which can result in missed opportunities due to a lack of experience in how to effectively transition patients. It is essential that nephrologists be informed equally on all modalities to establish clear pathways that prioritize home care over in-center options when appropriate for patients. By identifying patients who would benefit from HHD early, health care providers can help avoid complications and hospitalizations that often accompany last-minute transitions.</p>
<h2><strong>Evolution of Kidney Care</strong></h2>
<p>The transition from peritoneal to home hemodialysis represents a crucial step in the evolution of nephrology care. By dispelling myths, leveraging technology, addressing logistical challenges, and improving the education of health care providers, smoother, more effective transitions for patients can be achieved.</p>
<p>The future of nephrology lies in innovative solutions that prioritize patient needs and lifestyles. As these transitions become more commonplace, it will be essential for health care systems to continue refining their approaches to ensure that every patient has access to the most appropriate, patient-centered care.</p>
<p><em>Michael Aragon, MD, is </em><em>board certified in internal medicine and nephrology. He is the </em><em>chief medical officer at Outset Medical, </em><em>where he leads clinical strategy and medical education initiatives to advance patient-centered care in dialysis. His clinical research has been focused on human factors and the expansion of dialysis options for patients with renal disease.</em></p>


Emily Menendez

Higher ADR Linked to Lower Incidence of CRC Post-Colonoscopy

Colorectal Cancer

Andrew Moreno

Real-World Data Study Gauges Survival Benefit from MDS Targeted Therapies by Mutation Type

ASH 2024

RBC Transfusion Dependency Linked to Reduced Overall Survival in Higher-Risk MDS

Latest News

Innovative Solutions in Nephrology: Navigating the Shift From Peritoneal to Home Hemodialysis

End-Stage Renal Disease

Dr. Michael Aragon of Outset Medical discusses the transition of patients from peritoneal dialysis to home hemodialysis.

About Us

Editorial Policy

Advertising

eNewsletters

Contribute

Contact Us

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

Mesothelioma

Non-Small Cell Lung Cancer

Small Cell Lung Cancer

Squamous Cell Lung Carcinoma

Lung Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

The Oncology Brothers

Rheumatology Rounds With Dr. Maheswaranathan

Healthcare Unfiltered

The Fellow on Call

Partners

Hurricanes & Health Care

Career Center

Expert Interviews

Subscribe